Unitree Robotics, one of China’s most prominent developers of quadruped and bipedal robots, has officially launched its initial public offering (IPO ) book-building process today, marking a watershed moment for the country’s rapidly accelerating embodied artificial intelligence sector. According to a report by the South China Morning Post, the Hangzhou-based company is listing on the Shanghai Stock Exchange’s STAR Market, a tech-focused board designed to support domestic innovation.
Unitree plans to sell 40.45 million shares, representing 10 percent of its enlarged share capital. The book-building process, which determines the final pricing of the shares based on institutional investor demand, begins on August 5, with the final offer price set to be determined the following day and the results published on August 14.
The IPO represents a significant maturation of China’s robotics industry, transitioning from a landscape dominated by venture-backed startups to one featuring publicly traded, capitalized enterprises capable of competing on a global scale. Following the listing, Unitree founder Wang Xingxing and related parties will retain a controlling interest, holding 31.29 percent of the company’s shares and 65.31 percent of its voting rights.
This structure ensures that the founding team maintains strategic direction over the company as it navigates an increasingly complex and competitive market. The listing follows closely on the heels of other highly successful STAR Market debuts, including ChangXin Memory Technologies (CXMT), which recently saw its market capitalization briefly exceed 4 trillion yuan ($592 billion), highlighting the immense domestic appetite for indigenous technology champions.
(Related: Unitree Robotics Opens IPO Book-Building August 5 in First-Ever Humanoid Robot A-Share Listing)
Geopolitical Timing and US Sanctions
The timing of Unitree’s public market debut is highly significant, occurring against a backdrop of intensifying technological rivalry between Beijing and Washington. The company’s IPO announcement came just days after the United States government announced an effective ban on the importation of new foreign-made robots, a regulatory move widely interpreted as a direct response to China’s rapid advancements and aggressive pricing in the robotics sector.
This geopolitical friction underscores the strategic importance of embodied AI, which both nations view as a critical component of future industrial competitiveness, military logistics, and advanced manufacturing. For Unitree, the U.S. import restrictions present a dual-edged sword. While the ban effectively closes off a lucrative consumer and enterprise market in North America, it simultaneously reinforces the company’s importance within China’s domestic industrial strategy.
The Chinese government has actively promoted the development of humanoid robots, designating them as a key pillar of the country’s “new productive forces.” By going public on the STAR Market, Unitree is securing the domestic capital necessary to accelerate its research and development, expand its manufacturing capacity, and pivot its sales strategy toward domestic industrial applications and alternative international markets in Southeast Asia and the Middle East.
(Related: FCC Bans Imports of New Chinese Humanoid and Quadruped Robots to Protect US AI Buildout)
The Shift from Quadrupeds to Humanoids
Unitree initially gained global recognition for its highly agile and aggressively priced quadruped “robot dogs,” which frequently drew comparisons to the much more expensive models produced by U.S.-based Boston Dynamics. However, the company’s recent strategic focus has shifted heavily toward bipedal humanoid robots, a far more complex engineering challenge that requires sophisticated embodied AI models for balance, manipulation, and environmental interaction.
The capital raised through this IPO will be critical for funding the development of these next-generation humanoids, which require massive investments in proprietary actuators, high-torque joint modules, and the compute infrastructure necessary to train advanced spatial perception models.
The race to commercialize humanoid robots in China is fiercely competitive. Unitree is contending with a crowded field of well-funded domestic rivals, including UBTech Robotics (which is already listed in Hong Kong), Agibot, and newer entrants backed by major tech conglomerates. To maintain its competitive edge, Unitree has historically relied on a strategy of aggressive cost reduction and rapid iteration, aiming to commoditize robotic hardware in the same way Chinese manufacturers previously commoditized drones and consumer electronics. The influx of public capital will allow Unitree to scale its production lines, further driving down unit costs and potentially accelerating the timeline for widespread commercial deployment of humanoid robots in factory and logistics settings.
A Bellwether for the Embodied AI Sector
Unitree’s performance on the STAR Market will be closely watched by investors and industry analysts as a bellwether for the broader embodied AI sector. While the technological demonstrations of humanoid robots have been highly impressive, the industry has yet to prove that these machines can generate sustainable, large-scale commercial revenue. The success of Unitree’s IPO will depend heavily on the company’s ability to articulate a clear path to profitability, demonstrating that its robots can move beyond viral marketing videos and deliver tangible return on investment for enterprise customers.
As the book-building process concludes and the shares begin trading, Unitree’s valuation will provide a critical benchmark for the dozens of other Chinese robotics startups currently waiting in the wings. A strong public market reception could trigger a wave of subsequent IPOs, flooding the sector with capital and further accelerating China’s push to dominate the global robotics industry. Conversely, a tepid response could force a consolidation among smaller players.
Regardless of the immediate market reaction, Unitree’s transition to a public company marks the end of the beginning for China’s humanoid robot race, shifting the focus from technological potential to commercial execution.
(Related: Morgan Stanley Doubles China Humanoid Robot Forecast Again: 50,000 Units Expected in 2026)